0001104659-18-009169.txt : 20180316 0001104659-18-009169.hdr.sgml : 20180316 20180213202655 ACCESSION NUMBER: 0001104659-18-009169 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DFB Healthcare Acquisitions Corp. CENTRAL INDEX KEY: 0001725255 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 823677704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 300 CENTRAL PARK WEST STREET 2: 7G CITY: NEW YORK STATE: NY ZIP: 10024 BUSINESS PHONE: 917-359-3042 MAIL ADDRESS: STREET 1: 300 CENTRAL PARK WEST STREET 2: 7G CITY: NEW YORK STATE: NY ZIP: 10024 CORRESP 1 filename1.htm

 

Goldman Sachs & Co. LLC

200 West Street, New York New York 10282

 

Deutsche Bank Securities Inc.

60 Wall Street, New York, New York 10005

 

February 14, 2018

 

VIA EDGAR

 

Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.

Mail Stop 3561
Washington, D.C. 20549

 

Attention: Laura Nicholson

 

Re:

DFB Healthcare Acquisitions Corp.
Registration Statement on Form S-1 (File No. 333-222376)

 

Dear Ms. Nicholson:

 

In connection with the above-referenced Registration Statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we hereby join in the request of DFB Healthcare Acquisitions Corp. that the effective date of the above-referenced Registration Statement be accelerated so that it will be declared effective at 4:00 pm EST on February 15, 2018 or as soon thereafter as practicable.

 

The following is supplemental information supplied under Rule 418(a)(7) and Rule 460 under the Act:

 

i.                  Dates of distribution: February 7, 2018 through the date hereof.

 

ii.               Number of prospectuses distributed: a total of approximately 2100 copies of the preliminary prospectus were distributed to prospective underwriters, institutional investors, dealers and others.

 

iii.            We have complied and will comply, and have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

 

[Signature page follows]

 


 

 

Sincerely,

 

 

 

 

 

GOLDMAN SACHS & CO. LLC

 

 

 

 

 

/s/ Elizabeth Word

 

Name: Elizabeth Word

 

Title: Managing Director

 

 

 

 

 

DEUTSCHE BANK SECURITIES INC.

 

 

 

/s/ Francis Windels

 

Name:

Francis Windels

 

Title:

Managing Director

 

 

 

/s/ Jennifer Sheng

 

Name:

Jennifer Sheng

 

Title:

Managing Director

 

[Signature Page to the Underwriters’ Acceleration Request]